Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0000905718-19-000779
Filing Date
2019-09-19
Accepted
2019-09-19 17:45:35
Documents
1
Period of Report
2019-09-13

Document Format Files

Seq Description Document Type Size
1 delmarph_fm4amsept132019.html 4/A  
1 delmarph_fm4amsept132019.xml 4/A 4878
  Complete submission text file 0000905718-19-000779.txt   6302
Mailing Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130
Business Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130 (858) 350-4364
DelMar Pharmaceuticals, Inc. (Issuer) CIK: 0001498382 (see all company filings)

EIN.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address 38 FALLBROOK LANE RR 33 CAMBRIDGE A6 N3H 4R8
Business Address
Bell John K (Reporting) CIK: 0001569585 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-37823 | Film No.: 191102358